Role of Embolization of Thyroid Arteries as a Treatment for Different Thyroid Disorders
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
To investigate the safety and efficacy of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Crossover
Treatments tested in this trial
selective embolization of thyroid arteries (SETA)
Procedure/Surgeryselective embolization of thyroid arteries
Treatment groups
20 Participants
are divided into 2 treatment groupsGroup A: graves disease patientsActive comparator 1 intervention
Group B: multinodular goiterActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
To investigate the safety of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders
Safety measured according to incidence of major and minor complications compared to thyroidectomy.
Time frame
Up to 12 months follow up after embolization2
To investigate the efficacy of selective embolization of thyroid arteries (SETA) as adjunctive or definitive treatment in different thyroid disorders
in hyperfunctiong (toxic) disorders Efficacy measured according to thyroid profile levels in certain time interval post procedure, every 3 months time interval and rate of hyper functioning recurrence in comparison to thyroidectomy. In diffuse or nodular goiter we measure efficacy by percentage of size reduction post procedure in comparison to primary size just before procedure
Time frame
Up to 12 months follow up after embolizationLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: